Δ8-Tetrahydrocannabinol (Δ8-THC) attenuates LPS-induced acute respiratory distress syndrome (ARDS) through immune-endothelial reprogramming 2300199
Acute Respiratory Distress Syndrome (ARDS) is a severe inflammatory lung disorder associated with high mortality. Currently, there are no FDA-approved pharmaceuticals approved for treatment of this disorder. This study evaluated the therapeutic potential of Δ8-Tetrahydrocannabinol (Δ8-THC), a cannabinoid that is...